The dominant theory in economics for centuries in the Western world has been the free market system, yet the ability of competitive markets to provide quality care has been a central point of recent debate. Extensive government regulation, though well-intentioned, adversely affects the overall health of Americans, inhibits medical innovation, and demands enormous tax-payer investment. The Initiative on Enabling Choice and Competition in Healthcare delivers cutting edge research on the efficiencies of competitiveness in the healthcare sector to demonstrate that free market forces can and do work to provide innovative, equitable, and high-quality care.
Our Vision
To be the leading university-based research center in free-market healthcare, promoting choice and competition to ensure greater access to existing care and new innovations.
Our Mission
To conduct evidence-based research and analyses on market-based choice and competition in the healthcare sector to lead to better-informed policy recommendations.
Working Papers
Economic Activity and the Value of Medical Innovation during a Pandemic
The “shutdown” economy of April 2020 is compared to a normally functioning economy both in terms of market and nonmarket activities. Three novel methods and data indicate that a full shutdown of “nonessential” activities puts market production about 25 % below normal...
The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19
The spread of COVID-19 in the United States has prompted extraordinary, although often untested, steps by individuals and institutions to limit infections. Schools, restaurants, entertainment venues, and many other places of business were required to close under the...
The Value of Employer-Sponsored Health Insurance
Employer-sponsored health insurance (ESI) is over a trillion-dollar market with about 160 million Americans (a majority) participating as plan members, of which about 80 million are policy holders. The policies are valuable not only to employers and employees, but...
Learn more about Operation Warp Speed:
In the Press
The SMART Prices Act is anything but smart | The Hill | 06/29/23
By Thomas Philipson America’s largest pharmaceutical companies continue to sound the alarm about last year’s Inflation Reduction Act. In late May,...
Mulligan, Philipson Cited in the 2023 Joint Economic Report | Report of the Joint Economic Committee Congress of the United States on the 2023 Economic Report of the President Republican Response | 6/27/2023
See citations on pp. 128, 129, 132, 133, 134, 145, 147, 151. View the full report here.
Three reforms that will lower Medicare costs and improve care | The Hill | 06/25/23
By Tomas J. Philipson Everyone wants to keep Medicare on solid financial footing. But getting agreement on how to go about it is a challenge,...
2024 ECCHC Supply-Side Economics in Healthcare Conference – Watch Now!
The 2024 ECCHC Supply-side Economics in Healthcare Conference convened both in-person and virtually on Friday, May 3. Watch the full conference, or individual presentations and learn more about the conference here!